|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Effect of single oral doses of sitagliptin, a dipeptidyl peptidase-4 inhibitor, on incretin and plasma glucose levels after an oral glucose tolerance test in patients with type 2 diabetes 显示文摘 | Herman GA Bergrnan A Stevens C etal | 2006 | J Clin Endocrinol Metab2006，91，11： | 1 |
| 2 | Effect of single oral doses of sitagliptin, a dipeptidyl peptidase-4 inhibitor, on incretin and plasma glucose levels after an oral glucose tolerance test in patients with type 2 diabetes 显示文摘 | Herman GA Bergman A Stevens C | 2006 | J Clin Endocrinol Metab2006，91，11： | 1 |
| 3 | Pharmacokinetics and pharmacodynamics of sitagliptin, an inhibitor of dipeptidyl peptidase IV, in healthy subjects: results from two randomized, double - blind,Placebo-controlled studies with single oral doses显示文摘 | Herman GA Stevens C Van Dyck K | 2005 | Clini- cal Pharmacology and Therapeutics2005，78，6： | 1 |
| 4 | The human mannose-binding protein gene显示文摘 | Sastry K Herman GA Day L | 1989 | Exp Med1989，170，4： | 1 |
| 5 | Tolerability and pharma-cokinetics of metformin and the dipeptidyl peptidase-4 inhibitorsitagliptin when co-administered in patients with type 2 diabe-tes显示文摘 | Herman GA Bergman A Yi B | 2006 | Curr Med Res Opin2006，22，10： | 1 |
| 6 | Pharmacokinetics and pharmacodynamics of sitagliptin,an inhibitor of dipeptidyl peptidase IV ,in healthy subjects:results from two randomized, double-blind,placebo-controlled studies with single oral doses显示文摘 | Herman GA Stevens C Van Dyck K et'al | 2005 | Clin Pharmacol Ther2005，78，6： | 1 |
| 7 | Once-daily sitagliptin, a dipeptidyl peptidase-4 inhibitor, for the treatment of patients with type 2 diabetes显示文摘 | Hanefeld M Herman GA Wu M | 2007 | Current Medical Research and Opinion2007，23，6： | 1 |
| 8 | Effectsin of single oraldoses of sitangliptin, a dipeptidase-4 inhibitor, onincretin andplasma glucose levels after an oral glucose toterance test in patientswith type 2 diabetes显示文摘 | Herman GA Beigman A Stevens C | 2006 | Clin Endocrinol METAB2006，91，11： | 1 |
| 9 | Pharmaeokinetics and pharmacodynamics of sitagliptin,an inhibitor of dipeptidyl pepti- dase IV ,in healthy subjects :results from two randomized, double- blind,placebo-controlled studies with single oral doses 显示文摘 | Herman GA Stevens C Van Dyck K | 2005 | Clin Pharmacol Ther2005，78，6： | 1 |
| 10 | Effeetsin of single oral doses of sitagliptin, a dipeptidyl peptidase-4inhibitor, on ineretin and plasma glueese levels after an oral glucose tolerance test in patients with type 2diabetes显示文摘 | Herman GA Bergman A Stevens C et 02 | 2006 | Clin Endoerinol bletab2006，91，1： | 1 |
| 11 | Once-daily sitagliptin, a dipeptidyl peptidase-4 inhibitor, for the treatment of patients with type 2 diabetes显示文摘 | Hanefeld M Herman GA Wu M | 2007 | Curt Med Res Opin2007，23，6： | 1 |
| 12 | Effect of single oral doses of sitagliptin,a dipeptidyl peptidase-4 inhibitor,on incretin and plasma glucose levels after an oral glucose tolerance test in patients with type 2 diabetes显示文摘 | HERMAN GA BERGMAN A STEVENS C | 2006 | J Clin Endocrinol Metab2006，91，11： | 1 |
| 13 | Evaluation of phar- macokinetic parameters and dipeptidyl peptidase-4 inhibi- tion following single doses of sitagliptin in healthy, young Japanese males 显示文摘 | Herman GA Mistry GC Yi B | 2011 | Br J Clin Pharmacol2011，71，3： | 1 |
| 14 | Pharmacokinetics and pharmacodynamic effects of the oral DPP-4 inhibitor sitaglipin in middle-aged obese subjects显示文摘 | HERMAN GA BERGMAN A LIU F | 2006 | J Clin Pharmacol2006，46，8： | 1 |
| 15 | Pharmacokinetics and pharmacodynamics of sitagliptin,an inhibitor of dipeptidyl peptidase Ⅳ,in healthy subjects:results from two randomized,double-blind,placebo-controlled studies with single oral doses显示文摘 | HERMAN GA STEVENS C VAN DYCK K | 2005 | Clin Pharmacol Ther2005，78，6： | 1 |
| 16 | Once-daily sitagliptin, a dipeptidyl peptidase-4 inhibitor, for the treatment of patients with type 2 diabetes显示文摘 | Hanefeld M Herman GA Wu M | 2007 | Curr Med Res Opin2007，23，： | 1 |
| 17 | The DP-Ⅳ inhibitor MK-0431 enhances active GLP-1 and reduces glucose following an OGTT in type 2 diabetics 显示文摘 | HERMAN GA ZHAO PL DIETRICH B | 2004 | Diabetologia2004，，1： | 1 |
| 18 | Pharmacokinetics andpharmacodynamics of sitagliptin, an inhibitor of dipeptidyl peptidase IV,in healthy subjects; results from two randomized, double-blind, placebo-controlled studies with single oral doses显示文摘 | Herman GA Stevens C Van Dyck K | 2005 | Clin Pharmacol Ther2005，78，： | 1 |
| 19 | Effect of single oral doses ofsitagliptin,a dipeptidyl Peptidase-4 inhibitor,on incretin and plasmaglucose levels after an oral glucose tolerance test in patients with type 2diatetes显示文摘 | Herman GA Bei^man A Stevens C | 2006 | J Clin Endocrinol Metab2006，91，11： | 1 |
| 20 | Effectsin of single oral doses of sitagliptin, a dipeptidyl peptidase-4inhibitor, on incretin and plasma glucose levels after an oral glucose toler ance test in patients with type 2 diabetes显示文摘 | Herman GA Bergman A Stevens C | 2006 | Clin Endocrinol Metab2006，，： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员